CBL and lung adenocarcinoma: We performed further detailed analyses on samples from three specific studies on patients with glioblastoma multiforme (n=136), lung adenocarcinoma (n=230) and head and neck squamous cell carcinoma (n=279), where EGFR protein levels were compared with c-CBL transcript levels.